Olema Pharmaceuticals (OLMA) Enterprise Value (2020 - 2026)
Olema Pharmaceuticals (OLMA) reported Enterprise Value of -$505.3 million for Q1 2026, down 28.68% year-over-year from -$708.6 million in Q1 2025, and little changed quarter-over-quarter from -$505.4 million in Q4 2025.
Olema Pharmaceuticals (OLMA) Enterprise Value (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 7 years of Enterprise Value data on file, last reported at -$505.3 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$505.3 million, down 28.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$505.3 million (down 28.68% YoY), and the FY2025 annual result was -$505.4 million, down 16.44% from the prior year.
- Enterprise Value steadied at -$505.3 million in Q1 2026 per OLMA's latest filing, from -$505.4 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$167.4 million in Q2 2023 and troughed at -$505.4 million in Q4 2025.
- A 5-year average of -$297.6 million and a median of -$261.8 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value surged 30.58% in 2023, then tumbled 65.8% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$204.4 million in 2022, then dropped by 28.07% to -$261.8 million in 2023, then plunged by 65.8% to -$434.1 million in 2024, then dropped by 16.44% to -$505.4 million in 2025, then rose by 0.02% to -$505.3 million in 2026.
- Business Quant data shows OLMA's Enterprise Value at -$505.3 million in Q1 2026, -$505.4 million in Q4 2025, and -$329.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Olema Pharmaceuticals | 1.01 Bn | 1.01 Bn | - | -505.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -505.35 Mn |
| Dec 31, 2025 | -505.44 Mn |
| Sep 30, 2025 | -328.96 Mn |
| Jun 30, 2025 | -361.91 Mn |
| Mar 31, 2025 | -392.71 Mn |
| Dec 31, 2024 | -434.09 Mn |
| Sep 30, 2024 | -214.76 Mn |
| Jun 30, 2024 | -239.10 Mn |
| Mar 31, 2024 | -248.98 Mn |
| Dec 31, 2023 | -261.81 Mn |
| Sep 30, 2023 | -276.90 Mn |
| Jun 30, 2023 | -167.44 Mn |
| Mar 31, 2023 | -185.95 Mn |
| Dec 31, 2022 | -204.42 Mn |
| Sep 30, 2022 | -222.60 Mn |
| Jun 30, 2022 | -240.71 Mn |
| Mar 31, 2022 | -267.87 Mn |
| Dec 31, 2021 | -287.25 Mn |
| Sep 30, 2021 | -305.95 Mn |
| Jun 30, 2021 | -318.14 Mn |